Health Trials

First Relapse

1

Review clinical trials related to First Relapse. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma

At present, there is no prospective study on the treatment of first-relapsed multiple myeloma with daratumumab plus pomalidomide and dexamethasone (Dara-Pd). A prospective, multicenter, open, non-interventional, observational clinical study to evaluate the efficacy and safety of Dara-Pd in patients with first relapse multiple myeloma.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: FengYan JinUpdated: Apr 3, 2026Locations: 1
Eligibility criteria

Age 18 years or older, regardless of gender. [+7]

Diagnosis of inactive multiple myeloma, including primary amyloidosis, MGUS (mon... [+6]

Read more